Clinical Trial Update: A Multiple Dose Study of TD-1211 in Healthy Volunteers and Patients With Opioid-Induced Constipation [Phase 1, Phase 2]

View source ↗

Summary

A multiple-dose clinical trial update for TD-1211 evaluating safety and pharmacology in healthy volunteers and patients with opioid-induced constipation (Phase …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid-induced Constipation

Drugs mentioned

• TD-1211

Snippet

Sponsor: Theravance Biopharma | Conditions: Healthy, Opioid-induced Constipation | Phase 1, Phase 2 | Status: COMPLETED